Archer Daniels Midland (NYSE: ADM), a leader in science-based nutrition solutions, has opened a new production facility in Valencia, Spain, with a $30 million investment to increase its production capacity five-fold and meet growing global demand for probiotics and postbiotics.

The facility will produce the company's award-winning probiotic B P L 1 and post biotic, as well as other proprietary strains, and support growth in Archer Daniels Midland UK-leading Bio-Kult brand.

The production facility is located near ADM's research and development center and aims to capture a share of the predicted $10.4 billion probiotic supplements market by 2027. The facility will support ADM's goal to increase its health and wellness revenue from $500 million to $2 billion within a decade.

Mark Lotsch, president, Global Health & Wellness at Archer Daniels Midland stated: “ADM is a leader in meeting this growing global demand, and we’re continuing to invest in the cutting edge of health and nutrition.”

ADM unlocks the power of nature to enrich the quality of life, and is a premier global human and animal nutrition company, delivering solutions today with an eye to the future.

Shares of Archer Daniels Midland trade on the NYSE under the ticker symbol ADM.